1-Chlorododecane

We are 1-Chlorododecane CAS:112-52-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-Chlorododecane
CAS.NO:112-52-7
Synonyms:1-Chlorododecane
chlorododecane
dodeceyl chloride
Dodecyl chloride
Dodecane,1-chloro
Molecular Formula:112-52-7
Molecular Weight:204.78000
 
Physical and Chemical Properties:
Density:0.867
Melting point:-9.3ºC
Boiling point:260ºC
Flash point:130ºC
Index of Refraction:1.443
 
Specification:
Appearance:Colorless transparent liquid
Assay(GC):≥99.0%
Moisture:≤0.2%
 
Packing:180 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

1-Chlorododecane


Related News: There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.814-49-3 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.3-Iodo-1-propanol acetate Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.656-42-8 At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.

Related Products
Product Name
ACETYL SH-HEPTAPEPTIDE-1 View Details
2-methyloxolan-3-one View Details
4-Fluoro-2-methylbenzonitrile View Details
3-FLUOROPROPAN-1-OL manufacturer 2,6-di(propan-2-yl)aniline manufacturer 2-Chloro-6-fluoronitrobenzene manufacturer 1-(2,3-Dichlorophenyl)piperazine hydrochloride manufacturer 2,6-Dichloro-4-methylphenol manufacturer